Advanced search
Publication Cover
Leukemia & Lymphoma Volume 44, 2003 - Issue 6
Submit an article Journal homepage
23
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Evaluation for the Development of 11q23 Rearrangements in Lymphoma Patients Treated with a High Dose VP-16 and Cyclophosphamide Salvage Regimen

Joy Mangel Division of Hematology, McGill University Health Centre, Montreal, Que., Canada
,
Alessandra Duncan Division of Cytogenetics, McGill University Health Centre, Montreal, Que., Canada
&
Silvy Lachance Division of Hematology, McGill University Health Centre, Montreal, Que., Canada
Pages 1001-1009 | Published online: 01 Jul 2009

  • Rybka, W.B. (1991) "Ablative therapy in bone marrow transplantation". Bane Marrow Transplantation 7(Suppl. 1), 60.
  • Cohen, S., Lacroix, L., Blake, G., et al. (1997) "High dose etoposide and cyclophosphamide therapy in refractory/relapsed lymphomasan update of 85 patients". Blood 90, 192a, (abstr #849).
  • Karp, J.E. and Smith, M.A. (1997) "The molecular pathogenesis of treatment induced (secondary) leukemias: foundations for treatment and prevention", Seminars in Oncology 24, 103-113.
  • Thirman, M.J. and Larson, R. A. (1996) "Therapy related myeloid leukemia". Hematology/Oncology Clinics of North America 10, 293-320.
  • Park, D. and Koeffler, H.P. (1996) "Therapy related myelodysplastic syndromes". Seminars in Hematology 33, 256-273.
  • Pedersen-Bjergaard, J., Philip, P., Larsen, S.O., et al. (1993) "Therapy related myelodysplasia and acute myeloid leukemia. Cytogenetic characteristics of 115 consecutive cases and risk in seven cohorts for patients treated intensively for malignant diseases in the Copenhagen series". Leukemia 7, 1975-1986.
  • Pederson-Bjergaard, J. and Philip, P. (1991) "Balanced translocations involving chromosome bands 11q23 and 21q22 are highlycharacteristic of myelodysplasia and leukemia following therapywith cytostatic agents targeting at DNA-topoisomerase II". Blood78, 1147-1148, (letter).
  • Pui, C.H., Ribeiro, R.C., Hancock, et al. (1991) "Acute myeloidleukemia in children treated with epipodophyllotoxius for acutelymphoblastic leukemia". New England Journal of Medicine 325,1682-1687.
  • Winick, N.J., McKenna, R.W., Shuster, J.J., et al. (1993)"Secondary acute myeloid leukemia in children with acutelymphoblastic leukemia treated with etoposide". Journal of ClinicalOncology 11, 209-217.
  • Pui, C.H., Relling, M.V., Rivera, G.K., et al. (1995) "Epipodophyllotoxin-related acute myeloid leukemia: a study of 35 cases".Leukemia 9, 1990-1996.
  • Whitlock, J.A., Greer, J-P. and Lukens, J.N. (1991 ) "Epipodophyllotoxin related leukemia. Identification of a new subset of secondaryleukemia". Cancer 68, 600-604.
  • Felix, C.A., Hosler, M.R., Winick, N.J., et al. (1995) "ALL-1 generearrangements in DNA topoisomerase II inhibitor related leukemia in children". Blood 85, 3250-3256.
  • Ratain, M.J., Kaminer, L.S., Bitran, J.D., et al. (1987) "Acutenonlymphocytic leukemia following etoposide and cisplatin combination chemotherapy for advanced non small cell carcinoma of the lung". Blood 70, 1412-1417.
  • DeVore, R., Whitlock, J., Hainsworth, J.D., et al. (1989) "Therapy related acute nonlymphocytic leukemia with monocytic features and rearrangement of chromosome 11q". Annals of Internal Medicine 110, 740-742.
  • Web, H.J., Kabitsch, H., Landbeck, G., et al. (1986) "Translocation(9;11)(p21;q23) in a child with acute monoblastic leukemia 2(1/2)years after successful chemotherapy for neuroblastoma". Journal of Clinical Oncology 4, 1518-1520.
  • Pedersen-Bjergaard, J., Daugaard, G., Hansen, S.W., et al. (1991)"Increased risk of myclodysplasia and leukemia after etoposide, eisplatin. and bleomycin for germ-cell tumors". Lancet 338,359-363.
  • Imashuku, S., Hibi, S., Kosaka, K., et al. (1996) "Secondary lymphoid malignancy in two children with oeuroblastoma".Medical and Pediatric Oncology 27, 54-56.
  • Gill Super, H.J., McCabe, N.R., Thirman, M.J., et al (1993)"Rearrangements of the MLL gene in therapy related acute myeloidleukemia in patients previously created with agents targeting DNA topoisomerase IT', Blood 82, 3705-3711.
  • Krishnan, A., Bhatia, S., Slovak, M., et al. (2000) "Predictors of therapy-related leukemia and myelodysplasia following autologous transplantation for lymphoma: an assessment of risk factors". Blood95, 1588-1593.
  • Traweek, S.T., Slovak, M.L., Nademanee, A.P., et al. (1994)"Clonal karyorypic hematopoietic cell abnormalities occurring after autologous bone marrow transplantation for Hodgkin's disease andnon-Hodgkin's lymphoma". Blood 84, 957-963.
  • Rubnitz, J.E., Behm, F.G. and Downing, J.R. (1996) "11q23 rearrangements in acute leukemia". Leukemia 10, 74-82.
  • Caligiuri, M.A., Strout, M.P. and Gilliland, G. (1997) "Molecular biology of acute myeloid leukemia". Seminars in Oncology 24,32-44.
  • Bernard, O.A. and Berger, R. (1995) "Molecular basis of 11q23 rearrangements in hematopoietic malignant proliferations". Genes, Chromosomes and Cancer 13, 75-85.
  • Schichman, S.A., Caligiuri, M.A., Gu. Y., et al. (1994) "ALL-1partial duplication in acute leukemia". Proceedings of the National Academy of Sciences of the United States of America 91,6236-6239.
  • Schichman, S.A., Canaani, E. and Croce, C.M. (1995) "Self fusion of the ALL-1 gene". Journal of the American Medical Association273, 571-576.
  • Caligiuri, M.A., Schichman, S.A., Strout, M.P., et al. (1994)"Molecular rearrangement of the ALL-1 gene in acute myeloidleukemia without cytogeneric evidence of 11q23 chromosomal translocations". Cancer Research 54, 370-373.
  • Caligiuri, M.A., Strout, M.P., Lawrence, D., et al. (1998)"Rearrangement of ALLI(MLL) in acute myeloid leukemia with normal cytogenetics". Cancer Research 58, 55-59.
  • Rooney, D.E., Czepulkowski, B.H., eds, (1992) Human Cyto-genetics-A Practical Approach Volume II. Malignancy and Acquired Abnormalities. Second Edition (Oxford University Press. New York).
  • Gustinech, S., Manfioletti, M., Del Sal, G., Schneider, C. and Carninci, P. (1991) "A fast method for high-quality genomic DNA extraction from whole human blood". Biotechniques 11, 298-300.
  • Ausubel, Frederick M., Brent, Roger, Kingston, Robert E., Moore, David D., Seidman, J.G., Smith, John A, Struhl, Kevin, eds. (1998) Current Protocols in Molecular Biology (Wiley, New York) Vol. 1.
  • Benneit, J.M., Catovsky, D., Daniel, M.T., et al. (1982) "Proposals for the classification of the myelodysplastic syndromes". British Journal of Hematology 51, 189-199.
  • Bennett, J.M., Catovsky, D., Daniel, M.T., et al. (1985) "Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French - American- British Group". Annals of Internal Medicine 103, 620-625.
  • Ross, W., Rowe, T., Glisson, B., et al. (1984) "Role of topoisomerase II in mediating epipodophyllotoxin-induced DNA cleavage". Cancer Research 44, 5857-5860.
  • Aplan, P.D., Chervinsky, D.S., Stanulla, M., et al. (1996) "Site specific DNA cleavage within the MLL breakpoint cluster region induced by topoisomerase II inhibitors". Blood 87, 2649-2658.
  • Sugita, K., Furukawa, T., Tsuchida, M., et al. (1993) "High frequency of etoposide (VP-16)-related secondary leukemia in children with non-Hodgkin's lymphom". American Journal of Pediatric Hematology-Oncology 15, 99-104.
  • Smith, M.A., Rubinstein, L., Anderson, J.R., et al. (1999) "Secondary leukemia or myelodysplastic syndrome after treatment with epipodophyllotoxins". Journal of Clinical Oncology 17, 569-577.
  • Travis, L.B., Curtis, R.E., Stovall, M., et al. (1994) "Risk of leukemia following treatment for non-Hodgkein's lymphoma". Journal of the National Cancer Institute 86, 1450-1457.
  • Travis, L.B., Curtis, R.E., Glimelius, B., et al. (1993) "Second cancers among long-term survivors of non-Hodgkin's lymphorna". Journal of the National Cancer Institute 85, 1932-1937.
  • Greene, M.H., Young, R.C., Merrill, J.M., et al. (1983) "Evidence of a treatment dose response in acute nonlymphocytic leukemias which occur after therapy of non-Hodgkin's lymphoma". Cancer Research 43, 1891-1898.
  • Pederson-Bjergaard, J., Ersboll, J., Sorensen, H.M., et al. (1985) "Risk of acute nonlymphocytic leukemia and preleukemia in patients treated with cyclophosphamide for non-Hodgkin's lymphomas. Comparison of results obtained in patients treated for Hodgkin's disease and ovarian carcinoma with other alkylating agents". Annals of Internal Medicine 103, 195-200.
  • Kaldor, J.M., Day, N.E., Clarke, E.A., et al. (1990) "Leukemia following Hodgkin's disease". New England Journal of Medicine 322, 7-13.
  • van der Velden, J.W., van Putten, W.L., Guinee, V.F., et al. (1988) "Subsequent development of acute non-lymphocytic leukemia after treatment for Hodgkin's disease". International Journal of Cancer 4, 252-255.
  • van Leeuwen, F.E., Chorus, A.M., van den Belt-Duscbout, A.W., et al. (1994) "Leukemia risk following Hodgkin's disease: relation to cumulative dose of alkylating agents, treatment with teniposide combinations, number of episodes of chemotherapy, and bone marrow damage". Journal of Clinical Oncology 12, 1063-1073.
  • Devereux, S., Selassie, T.G., Vaughan Hudson, G., et al. (1990) "Leukaemia complicating treatment for Hodgkin's disease: the experience of the British National Lymphorna Investigation". British Medical Journal 301, 1077-1080.
  • O'Reilly, S.E., Klimo, P. and Connors, J.M. (1991) "The evolving role of etoposide in the management of lymphomas and Hodgkin's disease". Cancer 67, 271- 280.
  • Darrington, D.L., Vose, J.M., Anderson, J.R., et al. (1994) "Incidence and characterization of secondary myelodysplastic syndrome and acute myclogenous leukemia following high-dose chemoradiotherapy and autologous stem cell transplantation for lymphoid malignancies". Journal of Clinical Oncology 12, 2527-2534.
  • Stone, R.M., Neuberg, D., Soiffer, R., et al. (1994) "Myelodysplastic syndrome as a late complication following autologous bone marrow transplantation for non-Hodgkin's lymphorna". Journal of Clinical Oncology 12, 2535-2542.
  • Friedberg, J.W., Neuberg, D., Stone, et al. (1999) "Outcome in patients with myelodysplastic syndrome after autologous bone marrow transplantation for non-Hodgkin's lymphoma". Journal of Clinical Oncology 17, 3128-3135.
  • Micallef, I.N.M., Lillington, D.M., Apostolidis, J., et al. (2000) "Therapy-related myelodysplasia and secondary acute myelogenous leukemia after high-dose therapy with autologous heraatopoietic progenitor-cell support for lymphoid malignancies". Journal of Clinical Oncology 18, 947-955.
  • Miller, J.S., Arthur, D.C., Litz, C.E., et al. (1994) "Myelodysplastic syndrome after autologous bone marrow transplantation: an additional late complication of curative cancer therapy". Blood 83, 3780-3786.
  • Pederson-Bjergaard, J., Anderson, M.K. and Christiansen, D.H. (2000) "Therapy-related acute myeloid leukemia and myelodysplasia after high-dose chemotherapy and autologous stem cell transplantation". Blood 95, 3273-3279.
  • Harrison, C.N., Gregory, W., Hudson, G.V., et al. (1999) "Highdose BEAM chemotherapy with autologous haematopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML". British Journal of Cancer 81, 476-483.
  • Pederson-Bjergaard, J., Pedersen, M., Myhre, J., et al. (1997) "High risk of therapy-related leukemia after BEAM chemotherapy and autologous stem cell transplantation for previously treated lymphomas is mainly related to primary chemotherapy and not to the BEAM-transplantation procedure". Leukemia 11, 1654-1660.
  • Andre, M., Henry-Amar, M., Blaise, D., et al. (1998) "Treatment related deaths and second cancer risk after autologous stem cell transplantation for Hodgkin's disease". Blood 92, 1933-1940.
  • Milligan, D.W., Ruiz de Elvira, M.C., Kolb, H-J., et al. (1999) "Secondary leuaemia and myelodysplasia after autografting for lymphoma: results from the EBMT". British Journal of Hematology 106, 1020-1026.
  • Chao, N.J., Nademanee, A.P., Long, G.D., et al. (1991) "Importance of bone marrow cytogenetic evaluation before bone marrow transplantation for Hodgkin's disease". Journal of Clinical Oncology 9, 1575-1579.
  • Abruzzese, E., Radford, J.E., Miller, J.S., et al. (1999) "Detection of abnormal pretransplant clones in progenitor cells of patients who developed myelodysplasia after autologous transplantation". Blood 94, 1814-1819.
  • Schnittger, S., Wormann, B., Hiddemann, W., et al. (1998) "Partial tandem duplications of the MLL gene are detectable in peripheral blood and bone marrow of nearly all healthy donors". Blood 92, 1728-1734.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.